Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEA-Polydatin for Chronic Pelvic Pain in Endometriosis
NCT02372903Completed
- Sponsor
- Università degli Studi di Cagliari
- Start
- Oct 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of palmitoylethanolamide and polydatin in endometriosis and chronic pelvic pain (CPP), sponsored by Università degli Studi di Cagliari. Primary endpoint: Change of Pelvic pain as measured by visual analogue scale at 90 days. Started Oct 2013; status: completed.
02
Drugs
palmitoylethanolamidepolydatin
03
Conditions
endometriosischronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT02372903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372903.